Literature DB >> 14644328

Mutagen sensitivity assays in population studies.

William W Au1.   

Abstract

Human population monitoring studies are frequently conducted to determine if exposure to environmental mutagenic agents can cause health problems or not. In these studies, a variety of biomarkers are used to identify biological events that are predictive of health consequences. An emphasis in this report is on the use of mutagen sensitivity assays to understand health risk. The assay is based on the assumption that exposure to mutagenic chemicals or mixtures of chemicals for a long time can cause cellular changes that are expressed as mutagen sensitivity. From experience in using these assays in cancer patients and in mutagen-exposed populations, it is clear that the expression of mutagen sensitivity is based on the interactions between mutagen exposure and individual susceptibility. When studies are conducted under appropriate conditions, expression of mutagen sensitivity is suggestive of increased risk for environmental disease such as cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644328     DOI: 10.1016/j.mrrev.2003.10.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  DNA damage phenotype and prostate cancer risk.

Authors:  O Kosti; L Goldman; D T Saha; R A Orden; A J Pollock; H L Madej; A W Hsing; L W Chu; J H Lynch; R Goldman
Journal:  Mutat Res       Date:  2010-11-21       Impact factor: 2.433

2.  Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers.

Authors:  Shuguang Leng; Christine A Stidley; Amanda M Bernauer; Maria A Picchi; Xin Sheng; Melissa A Frasco; David Van Den Berg; Frank D Gilliland; Richard E Crowell; Steven A Belinsky
Journal:  Carcinogenesis       Date:  2008-05-21       Impact factor: 4.944

3.  Assessment of in vitro cytotoxic and genotoxic activities of some trimethoprim conjugates.

Authors:  Devrim Güzel Bayülken; R Beklem Bostancıoğlu; A Tansu Koparal; Berrin Ayaz Tüylü; Aydan Dağ; Kadriye Benkli
Journal:  Cytotechnology       Date:  2018-01-15       Impact factor: 2.058

4.  Application of mutagen sensitivity assay in a glioma case-control study.

Authors:  Serap Erdal; Bridget J McCarthy; Natalia Gurule; Marianne Berwick; Emily Gonzales; Johanna Byrd; Kristina Flores; JoAnna Shimek; Dora Il'yasova; Francis Ali-Osman; Darell D Bigner; Faith G Davis; Alexis N Leyba; Kirsten A M White
Journal:  Toxicol Rep       Date:  2018-01-09

5.  DNA repair deficiency as a susceptibility marker for spontaneous lymphoma in golden retriever dogs: a case-control study.

Authors:  Douglas H Thamm; Kristen K Grunerud; Barbara J Rose; David M Vail; Susan M Bailey
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.